Skip to content

Author

Amanda W. Lund

We have 7 of 31 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Cancer cell adaptations along a proliferation–robustness axis drive TME pro-tumor phenotypes

Tumors are highly complex dynamic ecosystems with causal relationships between cancer cells and their tumor microenvironment (TME). To disentangle these interactions, we performed long-term co-culture experiments with cancer cells evolving alongside continuously replenished fibroblasts or macrophages. This allowed us t...

M. Pour, Gui-Sheng Zhao, Angeliki Karatza et al. · 0 citations
Open access Oct 2026

Lymphatic constraint of germinal centers optimizes protective antibody responses

Summary Immunization strategies are central to pathogen control, where efficacy relies on antigen distribution and inflammatory context. Lymphatic vessels are necessary conduits for antigen transport that actively remodel in peripheral tissues and draining lymph nodes (LN) in response to their inflammatory context. In...

Tenny Mudianto, Gabrielle R. Berman, K. Zaldaña et al. · 1 citation
Sep 2026

Abstract PR015: Clonal Heterogeneity in Human Pancreatic Ductal Adenocarcinoma and Its Impact on Tumor Progression

Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer characterized by profound desmoplasia and cellular heterogeneity, which cannot be fully resolved using traditional bulk sequencing approaches. To understand how this heterogeneity contributes to PDAC biology, we analyzed a large cohort of primary tumors...

Despoina Kalfakakou, Sungsik Kim, Li-Dong Wang et al. · 0 citations
Open access Sep 2026

Genotype-driven tumor ecosystems drive immune evasion and immunotherapy resistance in melanoma

This study links an understudied melanoma driver to specific immune-evasion mechanisms and identifies EGFR inhibition as a candidate strategy to improve outcomes in patients with NF1-mutant melanoma resistant to immunotherapy.

Milad Ibrahim, Irineu Illa-Bochaca, T. Muijlwijk et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.